Euroasian journal of hepato-gastroenterology

Register      Login

VOLUME 13 , ISSUE 2 ( July-December, 2023 ) > List of Articles

Original Article

Prevalence and Predictors for Respiratory Viral Infections among Liver Disease Patients

Jasmine Samal, Tushar Prabhakar, Manya Prasad, Nitiksha Rani, Bansidhar Tarai, Reshu Agarwal, Abhishek Padhi, Arvind Tomar, Rakhi Maiwall, Debajyoti Bhattacharyya, Manoj Kumar Sharma, Ekta Gupta

Keywords : Cirrhosis, Gender, Influenza, Liver, Noninfluenza, Respiratory viral infection, Seasonality

Citation Information : Samal J, Prabhakar T, Prasad M, Rani N, Tarai B, Agarwal R, Padhi A, Tomar A, Maiwall R, Bhattacharyya D, Sharma MK, Gupta E. Prevalence and Predictors for Respiratory Viral Infections among Liver Disease Patients. Euroasian J Hepatogastroenterol 2023; 13 (2):108-114.

DOI: 10.5005/jp-journals-10018-1400

License: CC BY-NC 4.0

Published Online: 26-12-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Aim and background: Respiratory viral infections (RVIs) cause significant hospitalizations every year. Also, RVIs caused by either influenza or noninfluenza group of viruses can have adverse outcomes, especially among immunosuppressed patients. Regular and timely supervision is needed for accurate etiological identification, to prevent inappropriate use of antibiotics in patients with nonbacterial etiology. This study aimed to identify the spectrum of RVIs and clinical characteristics among liver disease patients with influenza-like illness (ILI). Materials and methods: In this study, medical records of patients with ILI, whose requests for respiratory viral testing came from September 2016 to December 2022 were retrospectively reviewed. Respiratory viruses were identified using FilmArray 2.0 respiratory panel (BioFire Diagnostics, USA). Results: Of the 1,577 liver disease patients with ILI, the overall prevalence of RVI was 28% (n = 449). Infection by noninfluenza viruses (NIVs) was detected in 329 patients (73%), higher than those infected with influenza viruses. In multivariable logistic regression analysis, female gender [odds ratio (OR): 2.5, 95% confidence interval (CI): 1.5–4.2], infection with influenza B (OR: 3.3, 95% CI: 1.09–9.9) and decompensated cirrhosis (OR: 3.9, 95% CI: 1.7–8.5) were independent risk factors for mortality. Regarding seasonality, influenza peaked in monsoons and winters, whereas NIVs circulated throughout the year. Conclusion: Overall, this study adds new knowledge regarding the incidence of RVI and the distribution of respiratory viral etiologies among liver disease patients with ILI. The findings highlight that female gender, decompensated cirrhosis, and influenza B infection are independently associated with poor clinical outcomes. Early etiological identification of viral causes of ILI could aid in an enhanced understanding of the prevalence of ILI and the timely management of the patients. Clinical significance: Respiratory viral infections can cause severe illness in individuals with underlying liver disease. Accurate diagnosis and risk stratification is crucial in mitigating the adverse health effects.


HTML PDF Share
  1. Hong HL, Hong SB, Ko GB, et al. Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia. PLoS One 2014;9(4):e95865. DOI: 10.1371/journal.pone.0095865.
  2. Ishiguro T, Kagiyama N, Uozumi R, et al. Clinical characteristics of influenza-associated pneumonia of adults: Clinical features and factors contributing to severity and mortality. Yale J Biol Med 2017;90(2):165–181. PMID: 28656006.
  3. Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalisation among U.S. adults. N Engl J Med 2015;373(5):415–427. DOI: 10.1056/NEJMoa1500245.
  4. Li H, Liu SM, Yu XH, et al. Coronavirus disease 2019 (COVID-19): Current status and future perspectives. Int J Antimicrob Agents 2020;55(5):105951. DOI: 10.1016/j.ijantimicag.2020.105951.
  5. Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 2020;63(3):457–460. DOI: 10.1007/s11427-020-1637-5.
  6. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382(13):1199–1207. DOI: 10.1056/NEJMoa2001316.
  7. Hellewell J, Abbott S, Gimma A, et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health 2020;8(4):e488–e496. DOI: 10.1016/S2214-109X(20)30074-7.
  8. Lee VJ, Chiew CJ, Khong WX. Interrupting transmission of COVID-19: Lessons from containment efforts in Singapore. J Travel Med 2020;27(3):taaa039. DOI: 10.1093/jtm/taaa039.
  9. Xu L, Ying S, Hu J, Wang Y, et al. Pneumonia in patients with cirrhosis: Risk factors associated with mortality and predictive value of prognostic models. Respir Res 2018;19(1):242. DOI: 10.1186/s12931-018-0934-5.
  10. Papic N, Pangercic A, Vargovic M, et al. Liver involvement during influenza infection: Perspective on the 2009 influenza pandemic. Influenza Other Respir Viruses 2012;6(3):e2–e5. DOI: 10.1111/j.1750-2659.2011.00287.x.
  11. Schütte A, Ciesek S, Wedemeyer H, et al. Influenza virus infection as precipitating event of acute-on-chronic liver failure. J Hepatol 2019;70(4):797–799. DOI: 10.1016/j.jhep.2018.11.015.
  12. Bénézit F, Loubet P, Galtier F, et al. Noninfluenza respiratory viruses in adult patients admitted with influenza-like illness: A 3-year prospective multicenter study. Infection 2020;48(4):489–495. DOI: 10.1007/s15010-019-01388-1.
  13. World Health Organization. Global epidemiological surveillance standards for influenza. Available at: http://www.who.int/influenza/resources/documents/WHO_Epidemiological_Influenza_Surveillance_Standards_2014.pdf. Accessed on: 12 July 2023.
  14. Anthony PP, Ishak KG, Nayak NC, et al. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 1978;31(5):395–414. DOI: 10.1136/jcp.31.5.395.
  15. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis J Hepatol 2018;69(2):406–460. DOI: 10.1016/j.jhep.2018.03.024.
  16. Samal J, Agarwal R, Soni A, et al. Co-infection of SARS-CoV-2 with other respiratory pathogens in patients with liver disease. Access Microbiol 2022;4(10):acmi000456. DOI: 10.1099/acmi.0.000456.
  17. Poritz MA, Blaschke AJ, Byington CL, et al. FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: Development and application to respiratory tract infection. PLoS One 2011;6(10):e26047. DOI: 10.1371/journal.pone.0026047.
  18. Koul PA, Broor S, Saha S, et al. Differences in influenza seasonality by latitude, northern India. Emerg Infect Dis 2014;20(10):1723–1726. DOI: 10.3201/eid2010.140431.
  19. Chadha MS, Potdar VA, Saha S, et al. Dynamics of influenza seasonality at sub-regional levels in India and implications for vaccination timing. PLoS One 2015;10(5):e0124122. DOI: 10.1371/journal.pone.0124122.
  20. Bajpai V, Gupta E, Mitra LG, et al. Spectrum of respiratory viral infections in liver disease patients with cirrhosis admitted in critical care unit. J Lab Physicians 2019;11(4):356–360. DOI: https://10.4103/JLP.JLP_6_19.
  21. Karolyi M, Pawelka E, Kelani H, et al. Gender differences and influenza-associated mortality in hospitalised influenza A patients during the 2018/19 season. Infection 2021;49(1):103–110. DOI: 10.1007/s15010-020-01537-x.
  22. Giurgea LT, Cervantes–Medina A, Walters KA, et al. Sex differences in influenza: The challenge study experience. J Infect Dis 2022;225(4):715–722. DOI: 10.1093/infdis/jiab422.
  23. Klein SL, Hodgson A, Robinson DP. Mechanisms of sex disparities in influenza pathogenesis. J Leukoc Biol 2012;92(1):67–73. DOI: 10.1189/jlb.0811427.
  24. Harrison PM. Management of patients with decompensated cirrhosis. Clin Med (Lond) 2015;15(2):201–203. DOI: 10.7861/clinmedicine.15-2-201.
  25. Liu WD, Yeh CY, Shih MC, et al. Clinical manifestations and risk factors for mortality of patients with severe influenza during the 2016–2018 season. Int J Infect Dis 2020;95:347–351. DOI: 10.1016/j.ijid.2020.04.013.
  26. Premkumar M, Devurgowda D, Dudha S, et al. A/H1N1/09 influenza is associated with high mortality in liver cirrhosis. J Clin Exp Hepatol 2019;9(2):162–170. DOI: 10.1016/j.jceh.2018.04.006.
  27. Couturier MR, Barney T, Alger G, et al. Evaluation of the FilmArray® respiratory panel for clinical use in a large children's hospital. J Clin Lab Anal 2013;27(2):148–154. DOI: 10.1002/jcla.21576.
  28. Hammond SP, Gagne LS, Stock SR, et al. Respiratory virus detection in immunocompromised patients with FilmArray respiratory panel compared to conventional methods. J Clin Microbiol 2012;50(10):3216–3221. DOI: 10.1128/JCM.00538-12.
  29. Layman CP, Gordon SM, Elegino–Steffens DU, et al. Rapid multiplex PCR assay to identify respiratory viral pathogens: Moving forward diagnosing the common cold. Hawaii J Med Public Health 2013;72(9 Suppl. 4):24–26.
  30. Loeffelholz MJ, Pong DL, Pyles RB, et al. Comparison of the FilmArray respiratory panel and prodesse real-time PCR assays for detection of respiratory pathogens. J Clin Microbiol 2011;49(12):4083–4088. DOI: 10.1128/JCM.05010-11.
  31. Pierce VM, Elkan M, Leet M, et al. Comparison of the Idaho Technology FilmArray system to real-time PCR for detection of respiratory pathogens in children. J Clin Microbiol 2012;50(2):364–371. DOI: 10.1128/JCM.05996-11.
  32. Rand KH, Rampersaud H, Houck HJ. Comparison of two multiplex methods for detection of respiratory viruses: FilmArray RP and xTAG RVP. J Clin Microbiol 2011;49(7):2449–2453. DOI: 10.1128/JCM.02 582-10.
  33. Soccal PM, Aubert JD, Bridevaux PO, et al. Upper and lower respiratory tract viral infections and acute graft rejection in lung transplant recipients. Clin Infect Dis 2010;51(2):163–170. DOI: 10.1086/653529.
  34. Ruggiero P, McMillen T, Tang YW, et al. Evaluation of the BioFireFilmArray respiratory panel and the GenMark eSensor respiratory viral panel on lower respiratory tract specimens. J Clin Microbiol 2014;52(1):288–290. DOI: 10.1128/JCM.02787-13.
  35. Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol 2023;21(3):195–210. DOI: 10.1038/s41579-022-00807-9.
  36. Freeman AM, Leigh TR Jr. Viral Pneumonia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020.
  37. Ezzine H, Cherkaoui I, Rguig A, et al. Influenza epidemiology and risk factors for severe acute respiratory infection in Morocco during the 2016/2017 and 2017/2018 seasons. Pan Afr Med J 2020;36:159. DOI: 10.11604/pamj.2020.36.159.21239.
  38. Hanada S, Pirzadeh M, Carver KY, et al. Respiratory viral infection-induced Microbiome alterations and secondary bacterial pneumonia. Front Immunol 2018;9:2640. DOI: 10.3389/fimmu.2018.02640.
  39. Nahon P, Lescat M, Layese R, et al. Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort). Gut 2017;66(2):330–341. DOI: 10.1136/gutjnl-2015- 310275.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.